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Introduction
Ex vivo gene transfer to keratinocytes remains an attractive strategy for the treatment of many genetic disorders owing to the ease with which the cells can be biopsied, cultivated, transduced by retroviral vectors and transplanted. 1 By this approach, we are using the epidermis as a target tissue for factor IX gene transfer, as a potential therapy for delivery of factor IX protein to the blood of haemophilia B patients. Such a concept has been proven feasible with low levels of factor IX being delivered to mouse plasma for 7 days. 2 More recent improvements in grafting and vector design have increased this to 30-40 days. 3, 4 The levels of protein detected in plasma after transduced cells are transplanted to animals are much lower than predictions based upon the high levels of gene expression observed in the same cells in culture. 2 This might be due to cell death or might be caused by a problem of transport to the plasma, although transgenic studies have shown that when factor IX 5 and human growth hormone 6 are placed under the transcriptional control of keratinocyte-specific regulatory elements, protein is detected in the plasma. Control experiments show that this is likely to be due to lymphatic drainage of the skin. expression in keratinocytes in vivo. 3, 8, 9 However, owing to the technical difficulties in assaying for gene expression and cell survival in an intact graft over time in a quantitative manner, the theory of promoter downregulation remains controversial. Studies in other cells have shown that housekeeping or tissue-specific promoter/enhancers can increase the duration of gene expression. 10, 11 If an increase in either the duration or level of factor IX expression is observed with constructs containing keratinocyte-specific enhancer elements, then it can be inferred that down-regulation of the promoter in vivo has been circumvented.
We have previously generated a series of retroviral vectors in which the human factor IX cDNA was placed under the transcriptional control of either the cytomegaloviral (CMV) immediate-early promoter/enhancer alone or as hybrids with keratinocyte-specific enhancers or regulatory elements. 4 These hybrids were constructed by linking 73 bp, 241 bp or 277 bp promoter-proximal regulatory regions of the human keratin 5 (hK5), human keratin 14 (hK14) or the human papilloma virus 16 (HPV-16) P97 gene elements, respectively, upstream of the immediate-early CMV promoter/enhancer. 4 The HPV-16 element is a classic enhancer element 12 whereas formal evidence that the K14 and K5 promoter-proximal elements used in the constructs are enhancers is lacking. However, deletion analysis of K14 promoter constructs 13 and transgenic expression of a short 90 bp long K5 promoter with its adjacent upstream sequence 14 suggests that both the K5 and K14 elements are likely to be enhancers. Normal human keratinocytes transduced by these vectors secreted factor IX into the conditioned culture medium. However, their proliferative potential was reduced, probably as a combined result of both low viral titres and G418-induced cytotoxicity. Furthermore, after grafting, donor keratinocytes terminally differentiated and became encapsulated by the host mesenchyme tissue. Together these problems prevented a comparison of the different vectors in vivo. 4 Here we have investigated the effect that the different keratinocyte-specific promoter-proximal elements exerted in vivo after transduced keratinocytes were transplanted to nude mice. The HaCaT keratinocyte cell line 15 was used as a model to overcome the problems associated with transduction/G418 selection 16 of normal human keratinocytes and the grafting procedure was modified to prolong the survival time of transplanted keratinocytes.
Results
HaCaT cells tolerate retroviral vector transduction and G418 selection; transduced cells secrete stable levels of factor IX into conditioned medium HaCaT cells were transduced with defective retroviral vectors ( Figure 1a ) containing factor IX under the transcriptional control of either the CMV immediateearly promoter/enhancer alone (LNCIX), the HPV-16 P97 promoter/enhancer alone (LNPIX), or hybrid 4 promoter/enhancers containing the CMV promoter/ enhancer together with the HPV-16 P97 enhancer (LNPCIX), the hK5 promoter-proximal element (LNK5CIX) or the hK14 promoter-proximal element (LNK14CIX). Despite the low viral titres of some of the producer clones (10 3 -10 6 colony forming units (c.f.u.) per 10 6 cells per 24 h), 4 HaCaT cells survived the transduction/G418 selection and were successfully expanded in culture to enable the conditioned medium to be assayed for the presence of factor IX antigen by ELISA.
HaCaT cells transduced by the vector LNCIX (CMV promoter/enhancer) produced the highest levels of factor IX ( Figure 1b ) and these were approximately five-fold higher than the levels from cells transduced by LNPCIXand LNK14CIX-transduced cells, 100-fold higher than LNK5CIX-transduced cells and 200-fold higher than LNPIX-transduced cells (Figure 1b) . The lowest levels of factor IX in HaCaT cells in vitro were seen when the HPV-16 enhancer was combined with its homologous promoter in LNPIX. This suggests that the strong CMV promoter/enhancer was required for a high level of transcription in the hybrid constructs. However, the levels of factor IX produced by HaCaT cells were lower than values established previously for primary human foreskin keratinocytes 4 transduced by the same retroviral vectors (Table 1) . Even when these differences are normalised for the 1.8-fold increase in factor IX from primary human foreskin keratinocytes over HaCaT cells transduced by LNCIX (nonkeratinocyte-specific CMV promoter/enhancer alone), the levels are still 7.8-fold and 9.8-fold higher for the LNPCIX and LNK5CIX vectors, respectively, in primary keratinocytes (Table 1) .
Unlike primary human foreskin keratinocytes, 4,16 the HaCaT cells tolerated the transduction/G418 selection without any signs of cytotoxicity; no reduction in growth potential was observed and the cells retained a basal morphological phenotype in culture characteristic of their initial isolation, 15 with no sign of terminal differentiation or senescence (data not shown). To illustrate this point, LNCIX-transduced HaCaT cells were serially cultivated in the presence of G418 and the levels of factor IX secreted into the conditioned medium were found to remain constant for the duration of five passages ( Figure 2 ). Moreover, after each 10-day passage, the number of cells harvested was between four-and 10-fold higher than the number of cells originally seeded, even 34-38, respectively. after the fifth passage. These cells continued to grow for over 3 months in serial cultivation (data not shown), showing that transduced HaCaT cells were continuing to proliferate in G418 medium.
Up-regulation by the hK5 proximal-promoter element and the HPV-16 enhancer after transduced HaCaT cells are skin grafted to mice To assess the performance of the different vectors in vivo, mice were skin-grafted with HaCaT cells transduced by the vectors LNCIX, LNPCIX, LNK5CIX and LNK14CIX and the results of human factor IX detected in plasma by ELISA up to 100 days are shown in Figure 3a -d, respectively. Of nine mice grafted with LNCIX-transduced (CMV promoter/enhancer) HaCaT cells (Figure 3a) , two (mice 6 and 8) failed to produce detectable levels of factor IX at any point whereas the remaining seven produced factor IX at levels of 0.05-0.3 ng/ml of plasma within 7-25 days of grafting and four of five mice (mice 2, 3, 5 and 9, but not 6) continued to produce factor IX within this range until death at 27-76 days. All seven mice grafted with LNPCIX-transduced (HPV-16 enhancer + CMV promoter/enhancer) HaCaT cells ( Figure 3b ) produced detectable levels of factor IX at some point after grafting, with five mice (mice 12-16) producing factor IX at 0.05-0.5 ng/ml of plasma within the first 25 days, four mice (mice 10, 11, 12 and 14) at 0.5-1.6 ng/ml at 45 days and four of six mice (mice 11, 12, 14 and 16, not 10 and 15) still positive at death at 72-91 days. One (mouse 19) of six mice grafted with LNK5CIX-transduced (hK5 element and the CMV promoter/enhancer) HaCaT cells ( Figure 3c ) failed to produce detectable levels of factor IX at any point after grafting, whereas three mice (mice 17, 18 and 20) produced 0.17-1.3 ng/ml factor IX of plasma between 25 and 50 days and two mice (mice 21 and 22) produced 0.06-0.14 ng/ml between 30 and 60 days. One mouse (mouse 17) continued to secrete factor IX at 0.1-1.0 ng/ml for seven of eight bleed samples over 180 days and remained in this range (0.21 ± 0.05 ng/ml, mean ± s.d.) at death at 205 days ( Figure 3c and data not shown). Of the four mice grafted with LNK14CIX-transduced (hK14 element and the CMV promoter/enhancer) HaCaT cells (Figure 3d ), one mouse (mouse 25) produced levels of factor IX which bordered upon the threshold of detectability (0.02-0.05 ng/ml), two mice were below this threshold (mice 24 and 26) and one mouse (mouse 23) was positive at 100 days (0.14 ng/ml) and 109 days (0.11 ± 0.04 ng/ml, mean ± s.d. (Figure 3d ) and data not shown).
These results show a wide variation in the levels of factor IX produced by individual mice grafted with a given vector which may be due in part to the variable success of keratinocyte survival with this technique (see Discussion) and/or the errors in quantifying the low levels of human factor IX in the small volumes of plasma by ELISA (see Materials and methods). However, when cohorts of mice were analysed, this variation became less significant enabling the emergence of a general hierarchy of hybrid promoter/enhancer vector activity of LNPCIX (HPV-16 enhancer) Ϸ LNK5CIX (hK5 element) Ͼ LNCIX (CMV promoter/enhancer alone) ӷ LNK14CIX (hK14 element).
The chamber became detached from the back of 13 mice between 12 and 70 days which often coincided with a decrease in the levels of factor IX (see Figure 3 legend). However, the skin rehealed and factor IX was still detected in nine of these mice indicating that some HaCaT cells had survived.
Figure 3 Vectors containing the HPV-16 enhancer and the hK5 element are up-regulated upon transplantation of HaCaT cells. Factor IX was quantified by ELISA of plasma samples taken from mice at different time-points after grafting with HaCaT cells transduced by: (a) LNCIX -mouse 1 (ᮀ), 2 (ȣ), 3 (᭺), 4 (᭝), 5 ( ), 7 (), and 9 (ᮄ). Since factor IX was not detected in mouse 6 at 8 days and 27 days and in mouse 8 at 6 days, these mice were omitted from the figure for clarity. (b) LNPCIX -mouse 10 (ᮀ), 11 (ȣ), 12 (᭺), 13 (᭝), 14 ( ), 15 ( ) and 16 (). (c) LNK5CIX -mouse 17 (ᮀ), 18 (ȣ), 20 (᭝), 21 ( ) and 22 (
Transduced HaCaT cells differentiate to produce a normal stratified epidermis which persists for at least 99 days To follow the fate of HaCaT cells upon transplantation, organotypic skin tissue was retrieved either from tissue culture before transplantation or from the intact chambers of 10 mice (from Figure 3) killed at different times (7-99 days) after grafting ( Figure 4 ). Optimised formation of the skin equivalent after 3 days in culture (ie at the time of grafting) shows a regular (unstained) collagen matrix of even thickness, with a layer of undifferentiated basal-like HaCaT cells one to two cells thick along the upper surface and MRC-5 fibroblasts along the lower surface (Figure 4a) . However, the addition of an excess of HaCaT cells (5 × 10 6 ) produced a thickened layer of keratinocytes -10-20 cells thick, which remained undifferentiated in culture (Figure 4b ) and resulted in abnormal differentiation upon transplantation (data not shown).
Therefore all grafting experiments reported here used the optimised skin equivalents shown in Figure 4a . One week after transplantation, the skin equivalent had adhered to the pre-formed granulation tissue and was covered by a two to three cell-thick layer of HaCaT cells which had not obviously differentiated (Figure 4c) . By 3 weeks, the HaCaT cells had differentiated to form a mature epithelium resembling normal epidermal tissue (Figure 4d ) consisting of a stratified architecture of tightly packed columnar basal cells, larger suprabasal cells and desquamating cornified tissue (Figure 4e high power) . HaCaT cells were present after this time (eg at approximately 4, 6, 9 and 11 weeks, data not shown) but, in general, they covered a small area of the collagen surface (eg at 72 days, Figure 4f ) yet were still identified as late as 99 days (Figure 4g ) -the latest time-point analysed. The reformed epithelium displayed slight parakeratosis (retention of nuclear remnants in the stratum corneum) at 3 weeks (Figure 4e ) which became more apparent over time (Figure 4f ). This is in agreement with the original characterisation of transplanted HaCaT cells. 15 A cellular infiltrate, possibly consisting of neutrophils, was apparent in the mesenchyme tissue beneath the collagen matrix ( Figure 4g) ; a similar infiltrate was occasionally seen (eg along the surface of the re-formed epithelium, Figure 4e ) in other mice, illustrating an inflammatory response associated with this grafting technique. No HaCaT cells were apparent on mouse 4, killed at 2 weeks (Figure 4h ) indicating that the grafting technique was not always successful.
To demonstrate that the keratinocytes were, in fact, human HaCaT cells and not derived from host-mediated re-epithelialisation beneath the chamber, immunoperoxidase staining was performed using SY5, a monoclonal antibody specific for human involucrin. 17 Even in the absence of SY5, a high nonspecific background stain was present, especially in the collagen matrix. However, this staining was less intense in the suprabasal layer of cells, beneath the stratum corneum where involucrin is usually expressed (Figure 5a ). In contrast, when SY5 was included, peroxidase staining was more intense in this suprabasal region indicating the presence of human involucrin, showing that these cells are of human origin (Figure 5b ).
Discussion
We have demonstrated that HaCaT cells are a useful model for ex vivo gene transfer studies because they remain viable both in vitro and in vivo after retroviral vector transduction/G418 selection and yet retain the ability to form a normal, stable epidermis upon transplantation. This enabled relatively low viral titre vectors to be tested in an in vivo system by circumventing the problems of stem cell transduction and/or G418-induced terminal senescence 4, 16 observed with primary foreskin-derived keratinocytes.
In each case, the addition of the HPV-16, hK5 or hK14 regulatory element upstream of the strong CMV promoter/enhancer in the transduced HaCaT cells downregulated factor IX gene expression in vitro (Figure 1b) . This was not unexpected since decreased expression levels had been observed before with the hK5 and hK14 promoter-proximal elements, but not with the HPV-16 enhancer, in transduced primary keratinocytes 4 -presumably because of some form of enhancer interference. Decreased gene expression, driven from the Moloney murine leukaemia virus (MoMLV) promoter/enhancer, has also been observed in other cell types, eg when a muscle-specific enhancer was inserted into the U3 region of the LTR after retroviral transduction of primary myoblasts. 18 Only upon differentiation into myotubes was upregulation observed. It must be emphasized that the hybrid retroviral constructs used here are quite different from those used to test a classic enhancer element, when enhancers are placed upstream of a basal, eg thymidine kinase, promoter lacking its own enhancer. 19 In culture, transduced HaCaT cells produced lower levels of factor IX compared with primary foreskinderived keratinocytes with each of the retroviral vectors studied (Table 1) . Although these lower factor IX levels may partly reflect different growth characteristics of the cells, the difference was especially marked in the case of LNPCIX-(HPV-16 enhancer) and LNK5CIX (hK5 element)-transduced HaCaT cells. The approximately eight-to 10-fold lower levels of factor IX (normalised for the difference in activity of LNCIX-transduced cells, Table 1 , bottom row) in HaCaT cells compared with primary keratinocytes cannot be explained by a difference in growth rate alone. Rather, this may be associated with the inability of HaCaT cells to differentiate beyond their basal phenotype in culture (Figure 4b and Ref. 15) compared with primary human keratinocytes, which differentiate to produce a heterogeneous population of both basal and suprabasal cells. 20 Although hK5 expression is usually restricted to the basal layer of epidermis, the particular 73 bp hK5 element used here in the LNK5CIX vector is known to be active (as part of a minimal 90 bp hK5 promoter) in the more differentiated suprabasal layers of the epidermis in transgenic mice.
14 Similarly, HPV-16 viral transcription is known to increase in the more differentiated suprabasal epithelial layers. 21 In contrast, the hK14 gene expression is restricted to the basal layer when used as part of a construct containing 2.5 kb of upstream and 700 bp of 3′ hK14 gene sequence in a transgenic mouse. 22 These known properties of the HPV-16 enhancer and the presumptive hK5 and hK14 enhancers are consistent with the observed expression levels in HaCaT cells and primary human keratinocytes in culture. This is most clearly documented by the ratio of factor IX expression -7.8, 9.8 and 1.0, respectively (Table 1 , bottom row) -the low level reflecting basal cell expression and the higher levels reflecting up-regulation of HPV-16 and hK5 in the suprabasal primary keratinocytes. It is perhaps surprising that such small elements can confer such a large difference in the ratio of factor IX expression and we cannot exclude that additional factors such as proviral copy number and site of integration may contribute to this effect.
Further evidence in support of differentiationmediated up-regulation of LNPCIX and LNK5CIX vectors was obtained after transduced HaCaT cells were transplanted to mice. It has previously been shown that HaCaT cells resume a normal program of differentiation after transplantation 15 and this observation was also true for vector-transduced, G418-resistant HaCaT cells which differentiated to form a mature epithelium after 3 weeks (Figure 4) . Despite the fact that LNPCIX (HPV-16) and LNK5CIX (hK5) vectors were only 20% and 1%, respectively, as active as LNCIX (CMV promoter/enhancer alone, Figure 1b ) in cultured HaCaT cells in vitro, after transplantation the levels were two to three times higher than the LNCIX vector (Figure 3 ). This up-regulation was most obvious after 2-3 weeks which coincided with the timing of differentiation observed histologically (Figure 4) . In contrast, the LNK14CIX vector was approximately 20-fold more active than the LNK5CIX vector in HaCaT cells in vitro (Figure 1b ), yet was extremely low in vivo following transplantation (Figure 3 ). This is consistent with the interpretation that the hK14 element (a presumptive enhancer) was not up-regulated upon differentiation (Table 1) .
Fenjves et al 23 detected unexpectedly high levels of recombinant apolipoprotein E in plasma, compared with endogenous protein, after mice were grafted with keratinocytes transfected with a tagged-apolipoprotein E construct. Endogenous protein was expressed only in the small basal cells whereas the recombinant protein was also expressed in the larger suprabasal cells, fractionated by Ficoll gradient centrifugation. The authors suggested that the higher than expected levels in vivo were due to recombinant apolipoprotein E expression in the expanded suprabasal compartment formed by the differentiation of cells upon grafting. It would therefore appear that directing transgene expression to the suprabasal layer may increase the level of transgene expression in the epidermis. The HPV-16 enhancer is known to contain two activator protein 1 (AP1) sites 24 which are thought to play a key role in the differentiation-dependent regulation of viral gene expression. 25 Similarly, the epithelial differentiation markers profilaggrin 26 and involucrin 27 are also considered to be up-regulated by the action of AP1. As no such AP1 sites have been located in the hK5 promoter proximal element 14 it remains unlikely that the action of AP1 alone accounts for the up-regulation of factor IX observed in the present study. However, similar suprabasal up-regulation may be possible with enhancers from the involucrin and profilaggrin genes.
Improvements to the grafting technique enabled the persistence of transplanted cells beyond the approximately 3-4 weeks reported previously. 4 Encapsulation of the donor keratinocytes by the host mesenchyme tissue was prevented by the presence of the collagen matrix, and together the pre-formed granulation tissue and MRC-5 fibroblasts increased the opportunity for matrix attachment (Figure 4 ). Histological identification of persisting grafted HaCaT cells always revealed a basal-like population of keratinocytes; stratum corneum alone, without these cells, was never found (Figure 4 ). In addition, because transduced HaCaT cells survived in culture for Ͼ3 months without senescing (see Results and Figure 2 ), it is unlikely that the entire population of HaCaT cells suffered the same fate of commitment to terminal differentiation, without continued proliferation, which prevented the survival of G418-resistant primary keratinocytes in a previous study. 4 Despite improvements enabling the persistence of keratinocytes as late as 99 days (Figure 4g ), the limitations of the grafting technique were still apparent in that: (1) not all the grafts were successful (Figure 4h) , which probably accounts for some mice in which factor IX could not be detected ( Figure 3) ; (2) the chamber was lost from approximately half of the mice, which although enabling stable incorporation of HaCaT cells into scar tissue, resulted in a decrease in the level, albeit stable, of factor IX produced (see Results and Figure 3) ; and (3) the area beneath the intact chambers covered by HaCaT cells decreased over time (see Results and Figure 4) despite the maintenance of a proliferating basal phenotype. This may be a result of too slow vascularisation and too great a thickness of the glutaraldehyde-fixed collagen matrix and/or inflammation (characterised by the cellular infiltrate in Figures 4e and g ) possibly caused by the prevention of wound closure by the chamber. These limitations probably exacerbate the mouse-to-mouse variation in the levels of factor IX seen with each vector. None the less, data were obtained over a 100-day period in sufficient numbers of mice to test the activities of the different vectors in vivo (Figure 3 ).
There was a downward trend in the levels of factor IX detected in the grafted mice after 50 days (Figure 3) , although some mice continued to produce low, stable levels of factor IX after this time (eg mouse 17 -see Results and Figure 3c) . A slow reduction in the survival of HaCaT cells, as mentioned above, was probably a major factor contributing to the decrease observed in factor IX after 50 days. However, other factors such as promoter down-regulation still cannot be ruled out, especially since mice 16, 21 and 22 all had undetectable levels of factor IX at the time of death at 72, 99 and 64 days, respectively (Figure 3) , even though keratinocytes were still present by histology (Figure 4 ). These cells were unlikely to be of mouse origin because they were found in patches along the surface of the matrix, and not as a continuous sheet of cells migrating from the wound margin. In addition, keratinocytes beneath the chamber were shown to be of human origin by immunoperoxidase staining with an antibody specific for human involucrin ( Figure 5 ). Moreover, host keratinocytes did not invade intact chambers in over 28 mock controls grafted by this technique, 28 in agreement with our own observations. Another possibility, that the identified cells were of HaCaT origin but did not contain the vector, was ruled out because transduced cells were cultivated under stringent conditions of G418 selection before transplantation.
This study underscores the difficulty in quantitatively assessing keratinocyte survival and promoter activity, over time, in grafted mice. Without such data, the phenomenon of promoter down-regulation and the degree to which it occurs remains in dispute. Recently, Choate and Khavari 9 demonstrated a decrease in immunofluorescent staining of a ␤-galactosidase marker gene after 4 weeks of grafting transduced human keratinocytes to mice, despite the persistent expression of endogenous human keratinocyte-specific genes and the maintenance of the vector, as shown by polymerase chain reaction. Such evidence supports the notion of complete promoter shut-off. This contrasts with the data presented here, at least for the first 75 days, which despite not ruling out some degree of down-regulation, does not support the theory of complete promoter shut-off. These results may be due to a difference in either the cell type (primary as opposed to HaCaT) or the serum conditions of keratinocyte cultivation (serum-free versus foetal calf, respectively) which may affect transcription factors/ chromatin structure after transplantation, or it may be due to the different retroviral vectors/ promoters used.
In combination, the HaCaT cell line and the improved grafting technique enabled vector transduction, G418 selection and long-term transplantation of keratinocytes to be accomplished, thus overcoming the problems which previously prevented the in vivo assessment of this series of vectors. The up-regulation mediated by HPV-16 enhancer and the hK5 presumptive enhancer element both in the primary keratinocytes and in the HaCaT cells following transplantation suggests that the keratinocytespecific enhancers may be useful in directing transgene expression to the suprabasal layer of grafted epidermis. This may increase the levels of gene expression after grafting in gene transfer protocols.
Materials and methods

Cultivation and retroviral vector transduction of HaCaT cells
The defective retroviral vector producer lines PA317-LNCIXc11, PA317-LNPCIXc14, PA317-LNK5CIXc22 and PA317-LNK14CIXc13 were isolated as described previously (Figure 1a and Ref. 4) . The plasmid pLNPIX containing the factor IX under the control of the HPV-16 P97 promoter/enhancer (positions 7500-83) 29 (ie without the CMV promoter/enhancer; Figure 1a ) was generated as follows: (1) the HPV-16 P97 promoter/enhancer fragment was amplified by Pfu (Stratagene, Cambridge, UK) polymerase chain reaction using the primers (forward) 5′ CGCTACCATGGAGATCTCTATGTCAGCAACTATG 3′ and (reverse) 5′ CGCTACCATGGTGGCTGTCTGCTT-TATACTAACCGG 3′ digested with NcoI (mutated sites introduced into the primers are underlined) and cloned into NcoI-cut pMFG-fIX (SJ White, personal communication) so that the third possible AUG start codon of factor IX coincided with the putative AUG start codon at postion 83 of HPV-16 P97 29 and the sequence flanking this start codon was mutated (shown in bold type in reverse primer) to match the Kozak consensus sequence; 30 (2) the resulting plasmid pMFG-P97-fIX was opened with BamHI, 'filled-in' with Klenow fragment of DNA polymerase I and the P97 promoter/enhancer factor IX cDNA fragment was excised with BglII, gel-purified and cloned in place of the CMV promoter/enhancer of BamHI-HpaI-cut pLNCX. 31 The authenticity of the HPV-16 P97 promoter/enhancer in the final pLNPIX clone was verified by automated DNA sequencing. The defective retroviral vector producer cell line AM12-LNPIXc7 was isolated as described 32, 33 and had a viral titre of 10 4 c.f.u. per 10 6 cells per 24 h. HaCaT keratinocytes 15 were cultivated in HaCaT medium (DMEM supplemented with 5% foetal calf serum, 2 mM glutamine and penicillin-streptomycin) and transduced at passage 31 by cocultivation with lethally irradiated (60 Gy) producer cell lines as described. 2 Transduced HaCaT cells were selected and maintained in 1 mg/ml G418 (Gibco BRL, Uxbridge, UK) for 2 weeks after establishing that a concentration of Ͼ0.8 mg/ml G418 was required to kill nontransduced HaCaT cells in 10 days. Factor IX antigen in conditioned medium from transduced HaCaT cells was quantified by enzymelinked immunosorbent assay (ELISA) 34 as a reporter for the internal promoter/enhancer activity. Expression from the 5′ long terminal repeat promoter is unlikely to contribute significantly to the levels of factor IX antigen since translation of the downstream factor IX cDNA from the longer long terminal repeat-derived transcript will be at best highly inefficient. 30 In addition, any residual contribution to factor IX antigen will be equal for all vectors. Furthermore, all factor IX transcripts initiated from the internal promoter contain identical backbone sequences and therefore will be subject to the same problems of mRNA stability, translational efficiency and aberrant splicing which could all affect the level of factor IX antigen.
Superficial skin grafting of HaCaT cells
HaCaT cells were grafted by a modified version of Boukamp et al 15 using a silicone transplantation chamber to prevent host re-epithelialisation of the graft bed, on to nude mice to minimise any immune response against xenogeneic keratinocytes and factor IX. A collagen matrix was prepared by exposing 200 l of calf skin type I collagen (3 mg/ml of 0.1 M acetic acid; Sigma, Poole, UK) in a silicone ring (Renner, Dannestadt, Germany) to 2% ammonia vapour until it had gelled (approximately 1 h). The acellular matrix was fixed in 4% glutaraldehyde for 1 h, washed extensively in phosphate-buffered saline followed by HaCaT medium overnight. The matrix was inverted and 5 × 10 5 MRC5 fibroblasts 35 were seeded on to the bottom surface, followed by 5 × 10 5 HaCaT cells on to the upper surface of the reverted matrix the following day. After 3 days in culture at the air-liquid interface, the 'hat-like' component of the transplantation chamber (Renner) was placed over the ring and the entire organotypic skin structure was embedded within a full thickness incision on the back of an 8-to 10-week-old male MF1 nu/nu mouse (Harlan Olac, Bicester, UK) on to granulation tissue pre-formed by the temporary implantation of a 13-mm glass disc (Renner) 2 weeks before skin grafting. These conditions of collagen thickness, glutaraldehyde fixation, HaCaT density and time in culture were optimised by histological assessment of skin equivalents formed in vitro (data not shown and Figure 4 ). Plasma from tail vein bleeds of mice was assayed for human factor IX antigen by a sensitive (generally 0.02-0.05 ng/ml) ELISA system. 4 Triplicate assays performed on plasma taken at death had a standard deviation ± 25-100% of the mean. Mice were humanely killed after different timepoints and the tissue beneath the chamber was processed for either routine haematoxylin and eosin or immunoperoxidase staining with SY5 (monoclonal anti-human involucrin antibody). 17 
